The role of the COVID-19 Special Operations largely depends on developments relative to the pandemic, so it is necessary to assess such developments and their impact on corporate financing when deliberating on the next steps.
Meanwhile, I am aware that there is a view among experts regarding the so-called zombie firm argument, which suggests that the life of firms that had low profitability and carried a high risk of future default even before the pandemic might be artificially extended.